Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients This Phase Ib/II study is an openlabel, multicenter study for patients with solid tumors and breast cancer amenable to anthracyclin therapy. The study is divided in two parts: Phas...

• Country Italy
• organs None
• Specialty None

Clinical Study Phase II of L19IL2 in Combination With Dacarbazine in Patients With Metastatic Melanoma This Phase II clinical study is an open-label, multicenter study of L19IL2 in combination with Dacarbazine in patients with metastatic melanoma. The study is divided in two parts: a phase...

• Country Austria, Germany, Italy, Switzerland
• organs None
• Specialty None

Combination Therapy of F16IL2 and Paclitaxel in Solid Tumour Patients This Phase Ib/II study is an open label, multicenter study. The study is divided in two parts: Phase I: an open-label, dose escalation study of F16IL2 in combination with paclitaxel for ...

• Country None
• organs None
• Specialty None